News
How one man, along with his care team, turned an all-consuming cancer diagnosis into a management strategy with inspiration ...
Cause Of Cancer,Chest X-ray,Computed Tomography Images ... Learning Convolutional Neural Network,Lung Cancer,Lung Cancer Screening,Lung Nodules,Neural Network,Neural Network Techniques,Non-small Cell ...
Topline data were announced from a phase 3 trial evaluating tarlatamab for the treatment of SCLC in patients who progressed on or after a single line of platinum-based chemotherapy.
An FDA-designated orphan drug that can target a key vulnerability in lung cancer shows promise in improving the efficacy of ...
YAP, a protein known to help cancer cells survive treatment, behaves very differently in cell culture models depending on how they are grown in the lab, highlighting the importance of mimicking tumour ...
Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of science, technology, and medicine news ...
“Optune Lua is an innovative and urgently needed new approach for treating metastatic non-small cell lung cancer,” said Joachim Aerts, M.D., a LUNAR investigator and Professor of Pulmonary ...
Oct. 9, 2024 — Researchers have demonstrated that patients with metastatic non-squamous non-small cell lung cancer (NSCLC) harboring specific mutations in the STK11 and/or KEAP1 tumor suppressor ...
5d
News-Medical.Net on MSNTargeted drug zongertinib shows strong results for HER2-mutant lung cancer in clinical trialThe HER2-targeted therapy zongertinib demonstrated clinical benefits for previously treated patients with advanced HER2-mutant non-small cell lung cancer – particularly those with specific HER2 ...
The study, published April 11 in The Annals of Thoracic Surgery, analyzed data from adults ages 40 to 64 with resected stage 1 or 2 non-small cell lung cancer between 2010 and 2016. Researchers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results